AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Metastatic breast cancer vaccine trial to continue.(Brief Article)
2002 NOV 27 - (NewsRx.com & NewsRx.net) -- Biomira, Inc., (BIOM), of Edmonton, Alberta, Canada, and Merck KGaA of Darmstadt, Germany, announced that they will continue their phase III clinical trial of Theratope vaccine through its planned conclusion in 2003.
This decision was made based on a recommendation from an independent review of interim data from their double-blinded randomized trial conducted in 1030 women with metastatic breast cancer. Theratope vaccine has fast-track designation with the U.S. Food and Drug Administration (FDA) for the treatment of metastatic breast cancer.
The Data Safety Monitoring board (DSMB) stated that they had "no safety concerns at all and recommend that the trial continue to final analysis." The DSMB also said they had "no safety concerns with continuing the present programs or initiating new trials under the current development plan."
Biomira and Merck KGaA, which are collaborating on the development of Theratope vaccine, reached this decision after the DSMB, an independent panel of cancer trial ...
- First patient enrolled in Theratope vaccine phase II trial.(Biomira Inc. and...
- Newspaper article from: Immunotherapy Weekly October 30, 2002 700+ words
...BIOM) and Merck KGaA announced that...with metastatic breast cancer who are being...with metastatic breast cancer. Approximately...these metastatic breast cancer patients. A...Biomira and Merck KGaA completed enrollment...
- MERCK KGAA STARTS PHASE III STUDY OF STIMUVAX IN BREAST CANCER.
- News wire article from: AsiaPulse News June 22, 2009 700+ words
...MERCK-KGAA) Merck KGaA Initiates Phase III Study of Stimuvax in Breast Cancer Merck KGaA announces the launch...Stimuvax, in advanced breast cancer DARMSTADT, Germany...Jun. 22, 2009-- Merck KGaA, Darmstadt, Germany...
- Merck KGaA Initiates Phase III Study of Stimuvax in Breast Cancer.
- Press release article from: Business Wire June 22, 2009 700+ words
...in advanced breast cancer DARMSTADT, Germany -- Merck KGaA, Darmstadt...sponsored by Merck KGaA, which is...with advanced breast cancer at an estimated...In aDvanced brEast cancer (b)START...was done by Merck KGaA. References...
- Merck KGaA Initiates Phase III Study of Stimuvax in Breast Cancer.(Report)
- Newspaper article from: Cancer Vaccine Week July 6, 2009 700+ words
...is sponsored by Merck KGaA, which is leading...Stimuvax (see also Merck KGaA). STRIDE will...with advanced breast cancer at an estimated...Unit Oncology, Merck KGaA. Keywords...AsiaBiotechnology, Breast Cancer, Breast Carcinoma...
- Biomira and Merck KGaA. (In the Pipeline).(Theratope breast cancer vaccine...
- Newspaper article from: Drug Utilization Review November 1, 2002 700+ words
Biomira and Merck KGaA have announced that investigators have enrolled the first patient in a Phase II trial of Theratope vaccine in women with metastatic breast cancer who are being treated with aromatase inhibitors or fulvestrant...
- BIOMIRA, MERCK KGAA MISS EARLY THERATOPE ENDPOINTS.(jointly investigating...
- Magazine article from: BIOWORLD Today Huggett, Brady September 20, 2002 700+ words
...result of Biomira Inc. and partner Merck KGaA ratcheting up the bar for Theratope...their Phase III trial in metastatic breast cancer was not an exalting triumph, but that...Theratope vaccine in women with metastatic breast cancer who are being treated with aromatase...
- Biomira Inc. (Active Pharmaceutical Ingredient Watch).(Biomira Inc and Merck...
- Magazine article from: Chemical Market Reporter June 30, 2003 700+ words
BIOMIRA Inc. and Merck KGaA report that vaccine Theratope has failed two predetermined end...and overall survival in a pivotal Phase III trial in metastatic breast cancer. Further analysis is underway of a subset of patients on hormonal...
- RISK LIES WITH MERCK KGAA ONCOTHYREON'S CANCER VACCINE STIMUVAX STARTS SECOND...
- Magazine article from: BIOWORLD Today Morrison, Trista June 23, 2009 700+ words
...cancer well underway, Merck KGaA started a second Phase...trial, this time in breast cancer, with Oncothyreon...never been tested in breast cancer patients, according...said the jump into breast cancer makes sense because...